Sandra Calvin
Förmögenhet: 2 M $ per 2026-05-31
Förmögenhet: 2 M $ per 2026-05-31
Sandra Calvin is currently Chief Accounting Officer & Senior Vice President at Travere Therapeutics, Inc., a position held since 2014.
Ms. Calvin completed undergraduate studies at San Diego State University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-14 | 42 353 ( 0,05 % ) | 2 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Comptroller/Controller/Revisor | 2014-12-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 2 |
|---|---|
San Diego State University
San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Travere Therapeutics, Inc.
Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån